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Physiologic studies in normal and uremic sheep: II. Changes in
erythropoiesis and oxygen transport. Red cell production and
survival, cardiac output (CO), renal blood flow (RBF), serum
erythropoietin (ESF), oxygen (02) consumption, 2,3-diphos-
phoglycerate (2,3-DPG), P50, and circulating hemoglobin (HbC)
were measured in normal sheep and in animals made chronically
uremic and anemic by subtotal nephrectomy. The erythropoiesis
characterizing uremic anemia was hypoproliferative as quan-
titated by ferrokinetics, but was still subject to normal feedback
control in that erythropoiesis in normal and uremic animals in-
creased with phlebotomy and was suppressed with transfusion.
ESF levels were only measurable when the hematocnt fell below
25 in normal animals and were undetected in most stable uremics
(hematocrit, 18 to 10%). HbC correlated with ESF. CO increased
linearly with progressive anemia in normal and uremic states but,
despite this increase, relative RBF decreased; the percent of the
CO going to the kidney fell with severe anemia. Venous 02 ex-
traction increased linearly in normal and uremic states as anemia
progressed, resulting in no differences in 02 utilization between
the study states. There were no correlations between 2,3-DPG,
P50, or hematocnt, under any conditions. These results confirm
the mechanism of anemia in chronic renal failure and demon-
strate that the 02 delivery ESF erythroid marrow feedback
mechanism persists in the uremic state over a wide range of he-
matocrits.
Etudes physiologiques chez le mouton normal et urémique: II.
Modifications de l'érythropoIèse et du transport d'oxygène. La
production et la durée de vie des hématies, le debit cardiaque
(CO), le debit sanguin renal (RBF), l'érythropoiétine sérique
(ESF), Ia consommation d'oxygène (02), le 2,3-diphosphoglyce-
rate (2,3 DPG), la P50, et l'hémoglobine circulante (HbC) ont été
mesurés chez le mouton normal et chez des animaux rendus uré-
miques chroniques et anémiques par néphrectomie subtotale.
L'érythropoièse caractéristique de l'urémie est hypoproliféra-
tive comme le mesure Ia cinétique du fer, mais elle est encore
soumise au rétro-contrôle normal en ce sens que l'érythropoièse
chez les animaux normaux et urémiques augmente avec Ia
saignée et est supprimée par les transfusions. Les concentrations
d'ESF sont mesurables seulement si l'hématocrite est inférieur a
25% chez les animaux normaux et ne sont pas détectables dans la
plupart des urémies stables (hématocrite, 18 a 10%). HbC est
corrélé avec ESF. CO augmente linéairement avec la progres-
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sion de l'anémie dans les situations normale et urémique, mais,
malgré cette augmentation, Ic RBF relatif diminue et Ia fraction
de CO allant au rein diminue quand l'anémie est sévère.
L'extraction veineuse d'02 augmente linéairement dans les situ-
ations normale et urémique au fur et a mesure que l'anémie prog-
resse, ce qui fait qu'il n'y a pas de difference dans l'utilisation
d'O2 entre les situations étudiées. Ii n'y a pas de correlation
entre le 2,3-DPG, la P50 ou l'hématocrite dans les diverses situa-
tions. Ces résultats confirment le mécanisme de l'anémie dans
l'insuffisance rénale chronique et démontrent que le système de
rétro-contrôle debit d'02-moelle osseuse persiste au cours de
l'urémie dans un grand éventail de valeurs de l'hématocrite.
One of the major complications of chronic renal
failure (CRF) is anemia. Prior studies of the mecha-
nisms of this anemia have emphasized the shorten-
ing of red cell survival [1—3], toxic depression of the
bone marrow [4, 5], prolongation of the erythroblast
intermitotic time [6—8] and, most importantly, de-
creased erythropoietin production by the diseased
kidney that results in marrow hypoproliferation [9,
10]. As determined by standard assay techniques,
serum erythropoietin levels in the uremic patient are
either unmeasurable or lower than anticipated for a
similar degree of anemia in nonuremic individuals
[11, 12]. More recently, however, Caro and Er-
slev have shown, using a modified assay, that plasma
erythropoietin levels of almost half of nonanephric
uremics were slightly above normal, although still
less than expected for similar anemia in nonuremic
subjects. In contrast, erythropoietin levels in aneph-
rics were below normal [13]. Despite this, erythro-
poiesis continues at a basal level and improves with
maintenance dialysis therapy [14].
Some of this improvement may be due to the
changes in the biochemical environment with dial-
ysis, but an increase in erythropoietin production
from renal and/or nonrenal sources with time prob-
ably also contributes.
Ervthropoiesis and oxygen transport in uremic sheep 733
Although red cell survival is shortened in many
patients with uremia, this finding is not universal,
and the degree of red cell destruction rarely ap-
proaches the normal erythron's capacity for com-
pensation. Of more concern is the question of the
presence of inhibitors of either erythropoietin or of
hematopoietic cellular proliferation in the uremic
state. This concern is made more than academic by
the likelihood that erythropoietin will become avail-
able for use therapeutically.
The quantitative relationships between the de-
gree of uremia and compensation for the anemic
state are not known, and it is not clear what role
dialysis may contribute to the improvement in the
uremic, anemic condition. The question of the pres-
ence and significance of erythropoietic toxins in the
uremic state is unresolved, and no meaningful clini-
cal trial of erythropoietin therapy has been under-
taken.
In this report, we have characterized oxygen
transport mechanisms and have quantitatively stud-
ied erythropoiesis and its responsiveness to the usu-
al feedback control mechanisms in the normal and
uremic state. For these studies, we have used
a large animal model of chronic uremia—the sub-
totally nephrectomized sheep [15]. Among the rea-
Sons the sheep was selected for such studies include
(1) cannula survival is long, permitting prolonged
vascular access [16]; (2) the animal can be studied
repeatedly because of its size and blood volume and
used as its own control; and (3) certain ruminants
have the unusual capacity to synthesize a structur-
ally distinct hemoglobin, hemoglobin C (HbC), in
response to erythropoietic stress [17, 18].
Methods
The methods involved in creating and maintain-
ing uremic sheep have been detailed previously [15,
16]. Sheep of hemoglobin AA phenotype (HbAA)
were used wherever possible, because these ani-
mals have the capacity to "switch" on hemoglobin
C synthesis when anemic or hypoxic. Iron stores
were maintained by administering iron dextran (Tm-
feron®, 1.5 g i.v.) following the initial cannulation.
This dose was repeated following a series of phie-
botomies and following the two-stage nephrectomy.
Hematopoietic measurements. Routine hemato-
logic determinations included hematocrit, hemoglo-
bin, red cell indices, white blood count, and platelet
count performed by an automated cell counter.
Quantitative ferrokinetic studies were carried out
by conventional means [19] and included measure-
ments of the plasma iron turnover, marrow transit
time, percent red cell utilization (day 9), erythroid
iron turnover and plasma volume, using either
iron 59 or iron 55 (ferric chloride) tagged to
autologous plasma. Blood volume was calculated
from the plasma volume and mean arterial hemato-
crit. Red cell survival was measured by labeling au-
tologous red cells with chromium 51. The percent-
age of HbC in peripheral red cells was determined
by cellulose acetate hemoglobin electrophoresis
(Tris-EDTA-borate buffer; pH, 8.9 to 9.3). Serum
erythropoietin levels were determined using the ex-
hypoxic, polycythemic mouse assay [20], quan-
titated by intra-assay comparison with concentra-
tions of the International Reference Preparation,
and expressed as units per milliliter.
Oxygen transport studies. Cardiac output (CO)
was measured with indocyanin green, and RBF was
measured with 131I-hippuran [21]. Oxygen consump-
tion was calculated from measuremens of arterial
blood gases and mixed venous Po2. Samples for
these determinations, as well as the CO, were ob-
tained by passing a Swan-Ganz catheter via the jug-
ular vein cannula into the pulmonary artery. Mea-
surements of whole blood P501 were determined us-
ing the mixing technique [22] and were performed in
the laboratory of the Division of Respiratory Dis-
eases. Intraerythrocytic 2 ,3-diphosphoglycerate
(2,3-DPG) levels were determined using the ion ex-
change technique [23].
Metabolic studies. Uremic sheep were monitored
with thrice-weekly serum determinations of creati-
nine, urea nitrogen, sodium, potassium, bicarbo-
nate, calcium, phosphorus, albumin, and alkaline
phosphatase, and of body weight. Dialysis, when
necessary, was also performed three times per
week. (Refer to Ref. 16 for results).
Results
Hematopoietic studies. (1) General (Table I).
The mean (± SD) hematocrit in 14 normal HbAA
sheep was 33.2 4.4% (N = 78). In 4 normal HbBB
sheep, the hematocrit was 31.8 2.8% (N = 18).
The mean hematocrit of 5 HbAB sheep was 36.6
4.4% (N = 28). The overall mean hematocrit for
normal sheep was 33.8 4.3%. The mean hemato-
crit of 4 stable, uremic sheep (creatinine, 6.1 3.1
mg/dl) was 16.9 2.4%, and in 7 dialyzed sheep
(predialysis creatinine, 6.9 2.2 mg/dl) it was 15.0
5.0%.
1 The P50 is that partial pressure of oxygen at which half the
hemoglobin is oxygenated.
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Table 1. Hematologic proffle of normal and uremic sheepa
Hct
vol% WBC
Platelet count
X1000
P1,,,
p.g/dl
Normal
Uremic, stabl&'
Uremic, dialyzede
33.8 4.3
(N=23)
16.9 2.4
(N = 4)
15.0 5.0
(N = 7)
7,030 632
(N= 13)
6,860 779
(N = 3)
6,464 1,430
(N = 5)
554 276
(N= 13)
362 21
(N = 3)
485 174
(N = 5)
153 51
(N= 18)
164 26
(N = 4)
143 4
(N = 7)
a Values are the means SD. There are no significant differences in WBC, platelet count, or plasma iron values between the three
study groups.
bCreatinine was 6.1 3.1 mg/dI.
Predialysis creatinine was 6.9 2.2 mg/dl.
The mean white blood cell count, platelet count,
and plasma iron values for normal and uremic sheep
also are listed in Table 1. Reticulocyte counts were
not routinely done because the normal values are
less than 0.1%.
(2) Ferrokinetics (Tables 2 through 5). The mean
plasma iron turnover, weighted for repeated studies
in several sheep, was 1.21 (± 0.28) mg Fe/di of
whole blood per day. Following phlebotomy to a
mean hematocrit of 22.3 5.4%, the plasma iron
turnover increased to 2.45 0.80 mg Fe/di of whole
blood per day (12 studies, 7 sheep, Fig. 1A). Hyper-
transfusion to a hematocrit of 37.8 3.4% sup-
pressed the plasma iron turnover to 0.72 0.07 (4
studies, 2 sheep, Fig. 2A).
In 12 studies in 4 stable, uremic sheep, the mean
plasma iron turnover was 1.02 0.24 mg Fe/dI of
whole blood per day at a hematocrit of 17.0 2.1%
(Fig. 1A) and was 0.79 0.69 mg in 7 dialyzed
sheep (13 studies) with a mean hematocrit of 14.6
4.4. The three study values in one dialyzed sheep
(no. 362) were, however, more than three times
greater than the mean of the other values (0.56
0.15 mg). In this group, the median value of 0.58
probably more accurately reflects erythropoie sis.
When the anemia was accentuated by daily
phlebotomy to a hematocrit of 11.1 1.8% in 3
stable, uremic sheep, the plasma iron turnover in-
creased to 1.67 0.55 (5 studies) (Fig. 1A). Thus, a
38% decrease in hematocrit resulted in a 70% rise in
the plasma iron turnover in the uremic sheep. These
values are similar to the twofold rise in plasma iron
turnover in the normal sheep when their hemato-
crits were reduced 35% by phlebotomy.
Table 2. Ferrokinetic data in normal sheepa
Sheep no.
Hct
vol %
Fe
,ig/dl
T'/2
mm
PIT
mgldl whole
blood/day
RBCU
%, 9 days
EIT
mg/dl whole
blood/day
MTIT
days
Bloodvol
ml/kg
13 35.0 116.0 68.0 1.11 50.0 0.56 1.96 61
17 32.0 274.0 106.0 1.77 87.0 1.56 2.35 47
18 35.6 170.0 84.0 1.30 56.4 0.64 1.90 51
119 34.2 144.0 72.0 1.38 38.6 0.52 1.90 42
122 32.5 120.0 90.0 0.90 92.7 0.83 2.36 43
318 33.0 154.0 86.0 1.23 82.4 1.01 2.30 54
324 32.0 155.0 85.0 1.25 74.7 0.93 3.30 54
363 27.5 76.0 45.0 1.22 79.1 0.97 3.10 59
373 35.0 202.0 79.0 1.66 50.9 0.84 2.60 56
394 30.2 189.0 87.0 1.44 44.9 0.78 3.55 61
395 32.6 142.0 98.0 0.98 57.3 0.56 3.10 52
6013 28.0 128.0 76,0 1.26 53.0 0.67 3.88 79
6013 29.5 138.0 98.0 1.04 60.5 0.83 3.33 59
7022 32.0 276.0 192.0 1.02 73.5 0.75 3.25 48
7039 35.8 202.0 161.0 0.85 66.3 0.56 2.90 —
8016 33.3 209.0 222.0 0.66 72.0 0.47 3.50 65
8016 32.0 171.0 108.0 1.13 84.0 0.94 3.50 —
Weighted mean 32.6 169.5 100.3 1.21 65.9 0.80 2.78 54.4
SD 16.5
N 17 17 17 17 17 17 17 14
a Abbreviations used are: PIT, plasma iron turnover; EIT, erythroid iron turnover; RBCU, red blood cell utilization; MTT, marrow
transit time; N, number of observations.
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Table 3. Ferrokinetic data in normal phiebotomized and transfused sheepa
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a Abbreviations are defined in Table 2.
PIT EIT
Hct Fe TV2 mg/di whole RBCU mg/dl whole
Sheep no. vol % pg/di mm blood/day %, 9 days blood/day
MTT
days
Bloodvol
mi/kg
A. Phlebotomized
17 23.5 169.0 57.5 2.25 98.0 2.20 1.0 51
17 20.5 220.0 58.0 3.06 50.0 1.53 0.9 44
18 24.3 57.0 29.0 1.49 63.5 0.94 2.1 45
18 27.7 77.0 30.0 1.87 — — — —
119 23.5 349.0 77.0 3.73 37.4 1.40 1.2 33
363 18.6 34.0 25.0 1.11 72.2 0.79 2.8 67
363 13.0 103.0 39.5 2.27 80.6 1.83 1.3 60
363 13.0 — — 2.78 — — — —
324 17.1 209.0 53.0 3.27 — — — —
13 31.0 — — 2.10 — — 2.2 35
395 19.0 — — 1.98 51.5 1.02 1.2 —
395 24.8 — — 1.32 — — — —
Weighted mean 22.3 177.6 49.9 2.45 60.6 1.31 1.6 44.8
SD 5.4 117.0 19.5 0.80 16.3 0.37 0.6 12.2
N 12 8 8 12 7 7 8 5
B. Transfused
363 31.9 125.0 93.0 0.92 48.1 0.44 3.6 59
363 39.1 166.0 166.0 0.61 36.1 0.22 5.6 52
6013 41.5 330.0 300.0 0.58 — — — 58
6013 39.0 317.0 276.0 0.75 — — — —
Weighted mean 37.8 234.5 208.8 0.72 42.1 0.33 4.6 56.8
SD 3.4 125.8 112.0 0.07 — — — 1,8
N 4 4 4 4 — — — 2
a Abbreviations are defined in Table 2.
Table 4. Ferrokinetic data in uremic, nondialyzed sheepa
PIT EIT
Hct Fe TV2 mg/dl whole RBCU mg/dl whole MTT Scr Blood vol
Sheep no. vol % g/dl mm blood/day %, 9 days blood/day days mg/dl mi/kg
A. Uremia
53 16.2 156.0 135.0 0.97 35.4 0.34 3.3 4.7 55
53 19.9 196.0 137.0 1.17 — — — 4.6 —
53 18.8 176.0 123.0 1.19 — — — 4.1 —
65 19.2 196.0 134.0 1.18 40.0 0.47 3.1 4.0 65
65 15.2 108.0 129.0 0.71 26.0 0.19 3.2 3.8 59
65 16.9 64.0 98.0 0.54 29.9 0.16 6.3 8.0 45
65 19.3 64.0 140.0 0.37 — — — 14.2 —
182 15.3 160.0 68.0 1.99 29.2 0.58 3.0 4.4 73
182 12.4 173.0 170.0 0.89 31.6 0.28 3.2 4.7 59
182 13.7 176.0 162.0 0.94 20.0 0.19 4.0 9.2 58
353 17.8 151.0 130.0 0.95 39.4 0.37 5.9 5.0 66
353 18.4 147.0 119.0 1.01 52.3 0.53 3.5 6.6 58
Weighted mean 17.0 150.7 128.7 1.02 35.0 0.35 3.90 6.0 59.2
2.1 30.7 4.5 0.24 8.0 0.07 0.67 1.2
N 12 12 12 12 9 9 9 12 4
B. Uremic, phiebotomized
53 9.3 257.0 111.0 2.10 40.9 0.90 1.8 5.1 62
53 10.8 104.0 123.b 0.75 — — — 7.1 —
65 10.1 146.0 65.0 2.02 61.6 1.24 2.5 5.6 57
65 10.0 168.0 81.0 1.87 — — — 4.0 —
353 13.2 136.0 72.0 1.62 59.1 0.96 2.9 3.0 69
Weighted mean 11.1 157.8 87.3 1.66 53.9 1.03 2.4 4.6 62.7
SD 1.8 22.3 25.7 0.26 11.3 0.18 0.56 1.6
N 5 5 5 5 3 3 3 5 3
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TableS. Ferrokinetic data in uremic, dialyzed sheepa
Sheep no.
Hct
vol %
Fe
g/dl
T1/2
mm
PIT
mg/dl whole RBCU
blood/day %, 9 days
EIT
mg/dl whole
blood/day
MTT
days
Scr
mg/dl
Blood vol
mi/kg
A. Uremic, dialyzed
62 16.0 169.0 262.0 0.54 39.8 0.24 3.6 8.8 92
65 13.3 133.0 334.0 0.35 21.9 0.08 3.6 9.6 70
65 8.5 73.0 170.0 0.39 — — — 9.6 —
182 8.5 155.0 259.0 0.54 — — — 9.5 65
318 26.0 118.0 122.0 0.70 88.6 0.62 4.9 4.2 52
318 18.1 111.0 115.0 0.79 70.4 0.56 3.0 3.3 61
324 14.7 94.0 195.0 0.41 36.0 0.15 2.4 7.5 60
362 11.2 193.0 46.0 3.67 46.5 1.70 1.2 4.6 70
362 14.8 147.0 75.0 1.66 34.0 0.56 2.8 5.4 84
363 22.2 209.0 292.0 0.56 46.1 0.26 3.9 5.5 60
363 16.8 111.0 128.0 0.72 52.3 0.38 3.2 6.1 56
363 11.0 107.0 164.0 0.58 — — — 6.4 51
Weightedmean 14.5 135.3 191.7 0.84 44.4 0.42 3.18 7.2 68.0
SD 4.4 31.5 77.1 0.81 19.3 0.39 0.79 2.3
N 7 7 7 7 6
B. Dialyzed, transfused
6 6 7 7
362 29.2 56.0 69.0 0.57 57.1 0.33 4.80 6.2 76
363 27.8 143.0 200.0 0.52 33.1 0.17 3.96 5.1 56
Mean 28.5 99.5 134.5 0.55 45.1 0.25 4.38 5.7 66.0
so 1.0 61.5 92.6 0.04 17.0 0.11 0.59 0.8 14.1
a Abbreviations are defined in Table 2.
Hypertransfusion was accomplished in 2 dialyzed
sheep. When the hematocrit was raised to 28.5
1.0% from 15.8 1.0%, the plasma iron turnover
was suppressed from 1.19 0.47 to 0.55 0.04 mg
(Fig. 2A).
Changes in the marrow transit time generally re-
flect the degree of erythropoietin stimulation [19].
The marrow transit time in 17 normal sheep aver-
aged 2.8 0.6 days and fell to 1.6 0.6 days when
the mean hematocrit was reduced by phlebotomy to
22.3 5.4% (Fig. 1B). The stable, uremic sheep had
a marrow transit time of 3.9 0.7 days, prolonged
30% above normal, although there was overlap be-
tween the two groups. Unfortunately, none of the
uremic sheep had been studied in the normal state,
so that direct comparisons were not possible. In re-
sponse to phlebotomy, however, the marrow transit
time in 3 uremic sheep shortened to 2.4 0.6 days
(3 studies, 3 sheep), a response similar to that of the
normal sheep subjected to phlebotomy (Fig. 1B). It
35
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Fig. 1. Erythropoiesis in normal and uremic sheep quantitated by plasma iron turnover (left side) and marrow transit times (right side) at
basal levels and after phlebotomy-induced anemia. The SD of the means are depicted (+). The numbers of sheep studied are given in
parentheses. Erythropoiesis increases in both uremic and normal sheep when the hematocrit is lowered by phlebotomy.
0.5 1.0 1.5 2.0 2.5 6.0 5.0 4.0 3.0 2.0
also lengthened when both normal and dialyzed
sheep were transfused (Fig. 2B), indicating that al-
terations in oxygen delivery lead to appropriate
changes in red cell production and iron kinetics in
both normal and uremic animals.
The red cell utilization of radioiron averaged 65.9
16.5% in 17 normal sheep. The mean erythroid
iron turnover (plasma iron turnover X percent utili-
zation) was 0.80 0.26 mg/dl of whole blood per
day (Table 5). Utilization was reduced to 35.0
8.0% in 9 studies of 4 uremic sheep (mean creatinine,
6.0 3.2mg/dl), contributing to the reduced erythroid
iron turnover of 0.35 0.07 mg. These findings in-
dicate that effective erythropoiesis is about one half
of "normal" in the uremic state but is only one
fourth of that expected of a normal sheep at a simi-
lar hematocrit. The mean red cell utilization in the
dialyzed sheep was 44.4 19.3% (10 studies in 5
sheep) at a hematocrit of 14.5 4.4%. The mean
erythroid iron turnover in this group was 0.42
0.39 mg (maximum creatinine level of 7.2 2.3 mg/
dl) (Table 5). Thus, a slight increase in effective
erythropoiesis was observed when the uremia was
improved by maintenance dialysis.
(3) Serum erythropoietin and hemoglobin C
(HbC) changes. Serum erythropoietin was unde-
tectable by conventional bioassay means in normal
sheep at hematocrits above 30%. Two normal sheep
with phlebotomy-induced anemia had serial
serum erythropoietin levels determined. At hemato-
crits of 20% and below, 0.11 to 0.16 U of erythro-
poietin per milliliter of serum was detected in ani-
mal no. 395; and in sheep no. 18, 0.12 to 0.36 U/nil
was detected between hematocrits of 25 and 17%
(Fig. 3). In contrast, erythropoietin remained unde-
tectable in the serum of a nondialyzed, uremic
sheep (no. 53; creatinine, 7.5 mg/dl) whose hemato-
cnt had been kept at 10% by daily phlebotomy (Fig.
Sheep 18
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Fig. 2. Effect of transfusion on 2 normal and 2 uremic sheep. Erythropoiesis decreased as measured by plasma iron turnover (left side)
and marrow transit time (right side) when the hematocrit was increased by 10 vol%.
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Fig. 3. Normal sheep that became anemic by daily phlebotomy.
Serum levels of erythropoietin (ESF) and percent of hemoglobin
C (HbC) in peripheral red cells increase appropriately.
5). But, 2 dialyzed sheep had detectable levels of
erythropoietin when their anemia was accentuated
by phlebotomy. The other dialyzed sheep did not
have erythropoietin levels determined. Sheep no.
65 had very high levels (1.36 to 1.55 U/ml) at hema-
tocrits below 18%. Sheep no. 362 (mean maximum
creatinine, 5.5 1.0 mg/dl) had undetectable levels
at a hematocrit of 18%, but up to 0.40 U/mi of
erythropoietin was found when the hematocrit was
lowered by phlebotomy to 11% (Fig. 5). Erythro-
poietin remained detectable (0.18 to 0.74 U/mI)
while the hematocrit was relatively stable between
12 and 17%.
The appearance of HbC synthesis is an indirect
way to monitor erythropoietin production. Figure 3
shows both the changes in HbC and serum erythro-
poietin levels as anemia was induced by phlebot-
omy in a normal HbAA sheep. This rise in HbC
was also observed in other anemic HbAA sheep. In
contrast, as shown in Fig. 4, 2 stable, uremic, anem-
ic sheep (nos. 53 and 353) failed to increase HbC
production significantly even when their hemato-
crits were reduced to 10% by daily phlebotomy.
But, uremic sheep no. 362, which required dialysis,
had elevated HbC levels and further increased syn-
thesis of HbC in response to the increased levels of
' ESF. HbC levels rose from a baseline of 6.7% to
34.5% following the reduction in hematocrit from
18.3 to 11.0%. In sheep no. 362, the ESF stimulus
led to an appropriate marrow response in that it re-
suited in a plasma iron turnover of 3.67 mg, which
was considerably greater than that seen in the other
dialyzed sheep (Table 5). Three other uremic, dia-
lyzed sheep failed to increase peripheral HbC levels
at hematocrit levels of 17%, but they were not
stressed with phlebotomy accentuation of their
anemia as was sheep no. 362. Sheep no. 65, the only
other dialyzed sheep with detectable erythropoietin
levels, was HbBB and, therefore, unable to switch
to HbC production. This suggests that in some ani-
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Fig. 4. Sheep nos. 53 and 353 made uremic by subtotal nephrectomy, with anemia developing within 30 days. (Sheep no. 53 was made
uremic 60 days before day 0 of this figure). Anemia was exaggerated to a hematocrit of 10 by daily phlebotomy after day 35, yet no
increase in erythropoietin (ESF) or peripheral red cell levels of hemoglobin C (HbC) occurred.
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Fig. 5. Correlations between hematocrit, percent HbC in periph-
eral blood, and serum erythropoietin (ESF) levels in sheep #362.
With subtotal nephrectomy (Y), the hematocrit fell, serum ESF
became consistently measurable, and the percent HbC increased
as the hematocrit approached 10%. Maintenance dialysis was be-
gun within 2 weeks of nephrectomy. With time, the hematocrit
gradually rose to 17 to 18% and the percent HbC declined stead-
ily.
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mals either the renal remnant is capable of respond-
ing to the anemic stimulus, or that nonrenal sources
assume more active ESF production.
(4) Red cell survival. Red cell survival (deter-
mined by chromium 51) in 3 normal sheep was 10.9
4.3 days as compared with 13.1 10.5 days in 3
studies in one uremic sheep (mean creatinine, 4.9
1.8 mg!dl). Six studies in 4 dialyzed sheep (mean
creatinine, 5.3 1.5 mgldl) disclosed a red cell sur-
vival of 8.8 2.5 days. These mean values are not
statistically different. These survival data in the
normal sheep are similar to that reported by Han-
sard and Kincaid [24] but half the value obtained by
Eadie, Smith, and Brown [25].
Oxygen transport studies (Table 6): (1) Cardiac
output (CO). Four normal sheep had serial mea-
surements of CO determined at various hemoglobin
levels, ranging from 14.0 (transfused) to 3.7 g/dl
(phlebotomy-induced). An inverse correlation was
observed in each sheep with correlation coefficients
ranging from —0.875 to —0.761.
Three sheep had CO studies before and after be-
coming anemic and uremic. Again, an inverse cor-
relation was seen. Only one sheep (no. 363), how-
ever, was studied in both conditions over a wide
range in hemoglobin concentrations (Fig. 6). Al-
though there was an inverse correlation between
hemoglobin and CO, at any given hemoglobin con-
centration, CO was lower in the uremic state than it
was in nonuremic sheep, suggesting an impaired re-
sponse in the uremic state.
(2) Renal blood flow and oxygen delivery to the
kidney. RBF and CO were determined in 4 normal
sheep over a wide range in hemoglobin concentra-
tions. The RBF increased slightly as anemia wors-
ened and CO increased in one animal (sheep no. 18,
Table 6A), but when the data from all animals were
analyzed, there was no correlation between these
two parameters (r = 0.252). In general, a modest
decrease in RBF was associated with increasing
anemia. Data for sheep no. 363 are shown in Fig.
7. When the fraction of the CO going to the kid-
neys was related, however, to hemoglobin levels, a
more dramatic reduction was found (r =
—0.588).
Thus, the lower the hemoglobin concentration, the
smaller the renal fraction of the CO. Data for sheep
no. 363 are shown in Fig. 7.
The mean percent of RBF per CO (Table 6) in
7 normal sheep was 16.9 5.0. This dropped to
10.0 4.0 when 4 of these sheep were phleboto-
mized to hematocrit levels of less than 20%. This
indicates that with increasing anemia, as CO in-
creases, there is shunting of blood away from the
kidney to other, presumably more vital, organs
[26, 27].
(3) Oxygen utilization. Oxygen utilization is the
product of the difference between the arterial and
venous oxygen saturations (expressed as volumes
of oxygen), the CO, and the hemoglobin concentra-
tion (X 1.34) [28]. As seen in Fig. 8, there were no
significant differences in oxygen utilization between
the study groups. The data represent 19 studies in 7
normal sheep, 9 studies in 3 anemic (Hb, 7.8 0.6
g/dl) sheep, and 8 studies in 3 severely anemic (Hb,
5.4 1.0 g/dl) sheep. The hemoglobin levels of the
stable, uremic sheep (5.6 1.1 g/dl) and the dia-
lyzed sheep (5.9 2.2 g!dl) were similar to the nor-
mal, phiebotomized sheep. Three additional studies
in 2 normal hypertransfused sheep and one study in
a dialyzed transfused sheep gave oxygen utilization
values within the normal range.
(4) Mixed venous oxygen tension (vPo2. Four
sheep had serial 'cPo2 measurements over a wide
range of hemoglobin concentrations. One sheep
(no. 363) was studied twice, while normal and dur-
ing uremia (Fig. 9). In both the normal and dia-
lyzed state, Po2 fell linearly with progressive
Sheep #363
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I
.
Normal!
r = 0.875
.0
=a
00
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0
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12 148 10
Hemoglobin, g/d/
Fig. 6. Cardiac output measured at different hemoglobin levels
of the same sheep but under normal and uremic conditions. Car-
diac output continues to increase with progressive anemia in
both conditions. Thereappears to be less cardiac response in the
uremic for similar levels of hemoglobin.
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Table 6. Oxygen transport parameters a
(Continued on facing page)
13
Hct Hb
Arterial
saturation
Venous
saturation CO RBF RBF/CO VPo2 02 utiliz.
Sheep no. StUdy' vol % gidi % % liters/mm mi/mm % mm Hg mi/mm
N 38.1 13.3 — — 5.76 1016 17.6 — —
N 38.0 13.3 — — 6.32 1190 18.8 — —
N 35.0 12.0 — — 6,31 1158 18.4 — —
P 29.0 9.9 — — 7.90 862 10.9 — —
P 31.0 10.6 — — 7.34 607 8.3 — —
P 30.0 10.4 — — 6.70 949 14.2 — —
P 31.0 10.8 — — 5.25 755 14.4 — —
P 25.5 8.8 — — 9.94 983 9.9 — —
P 17.0 5.4 — — 9.60 964 10.0 — —
18 N 33.0 11.6 98 80 5.14 — — 42 144
N 29.0 10.2 99 77 5.52 892 16.2 41 166
N 29.4 11.0 99 76 4.71 — — 40 160
P 22.4 7.6 99 81 5.80 393 6.8 41 106
P 23.6 8.3 99 73 7.19 547 7.6 36 208
P 22.9 7.9 99 59 5.67 263 4.6 32 240
P 17.6 5.9 99 53 6.86 652 9.5 28 250
P 19.1 6.6 99 72 7.34 1256 17.1 33 175
P 13.0 4.6 98 63 6.90 1153 16.7 29 149
53 U 22.0 7.3 98 71 5.15 — — 37 136
UP 9.8 3.7 98 58 4.07 — — 28 81
65 U 20.5 7.0 98 55 5.52 — — 40 23
318 N 27.9 10.1 99 81 4.25 956 22.5 39 104
N 28.9 10.5 99 77 6.57 480 7.3 37 203
N 28.5 10.0 99 79 7.23 — — 39 —
UD 26.0 8.9 — — 2.92 — — — —
UD 20.0 6.9 98 41 3.16 165 5.2 22 167
UD 19.0 6.5 99 46 — — — 22 —
324 N 30.7 11.2 99 73 4.90 433 8.8 36 191
N 30.8 11.3 99 77 3.13 858 27.4 39 104
N 32.1 11.6 98 76 — 708 — 38 —
P 16.6 5.5 99 60 — 329 — 28 —
P 17.0 5.0 99 53 — — — 25 —
P 12.3 4.0 98 67 — 420 — 32 —
P 17.0 5.2 — — 6.13 — — — —
353 N 24.0 8.1 — — — 589 — — —
U 16.4 5.6 — — 4.73 200 4.2 29 —
U 13.8 5.0 99 79 5.67 224 4.0 40 76
U 15.7 5.0 98 50 7.84 — — 25 252
U 11.5 4.3 99 40 9.83 110 1.1 22 334
U 13.3 4.3 99 56 10.21 — — 26 253
U 15.3 5.2 99 64 — 185 — 32 —
U 16.5 5.7 99 54 10.30 231 2.2 27 354
U 17.0 5.9 99 67 7.80 232 3.0 30 197
U 18.0 6.2 99 70 8.90 210 2.4 33 200
362 N 32.0 9.9 98 84 4.65 907 19.5 42 86
N 25.0 9.8 98 75 4.84 939 19.4 37 146
N 30.0 11.1 99 75 4.95 723 14.6 35 177
UD 13.2 4.0 99 50 — 70 — 24 —
UD 16.2 6.7 99 57 7.78 105 1.3 28 300
UD 17.7 7.3 98 86 5.38 105 2.0 47 63
395 N 34.9 12.1 98 74 5.74 776 13.5 35 223
N 35.0 12.4 98 85 4.08 498 12.2 44 88
N 32.0 10.9 98 82 5.19 724 13.9 42 121
P 22.3 7.6 99 76 7.38 655 8.9 40 173
P — — 99 70 — — — 30 —
P 25.9 8.4 99 63 6.30 907 14.4 29 184
P 23.3 7.9 98 64 6.18 472 7.6 31 223
P 21.0 9.0 99 29 6.16 567 9.2 28 520
P 18.0 6.1 99 57 6.18 424 6.9 27 218
P 18.0 6.1 99 62 6.55 439 6.7 29 198
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Sheep no. Studyb
Hct
vol %
Hb
gidi
Arterial
saturation
%
Venous
saturation
%
CO
liters/mm
RBF
mi/mm
RBF/CO
%
VPo2
mm Hg
02 utiliz.
mi/mm
363 N 33.0 9.6 98 58 5.08 844 16.8 29 258
N 28.0 9.7 99 68 4.65 978 21.0 31 200
N 30.5 10.4 99 71 4.06 807 19.9 38 158
P 24.0 8.5 98 66 5.69 562 9.9 32 207
P 22.0 7.5 99 61 5.44 — — 31 208
P 19.6 6.6 98 62 6.74 813 12.1 30 244
P 12.0 5.0 99 69 8.65 649 7.5 35 174
P 12.0 5.2 98 56 6.66 427 6.4 28 195
P 11.5 3.7 99 73 8.77 651 7.4 36 113
T 43.0 12.1 98 68 2.51 412 16.4 34 122
T 42.0 13.7 98 78 5.16 910 17.6 42 190
T 40.0 13.0 98 57 3.51 510 14.5 29 251
T 42.0 14.0 99 97 3.58 521 14.6 — —
UD 25.0 9.1 98 70 — 94 — 34 —
UD 22.0 8.2 97 67 4.25 115 2.7 33 140
UD 20.0 7.8 99 61 4.00 — — 29 159
UD 18.0 6.8 98 55 4.99 91 1.8 28 1%
UD 11.0 3.6 99 52 7.61 — — 27 173
UD 7.2 2.4 99 50 7.94 — — 25 125
UD 9.5 3.1 99 53 7.63 — — 28 146
IJDT 31.0 9.4 — — 4.00 210 5.3 — —
UDT 33.0 10.0 98 75 4.36 — — 38 134
UDT 29.0 10.6 98 65 — — — 34 —
a co is cardiac output; RBF, renal blood flow; VP02, mixed venous oxygen tension.
bN = normal; P = phlebotomy; T = transfused; U = uremia; D = dialyzed.
anemia, and the relationships were similar for both
groups.
(5) Oxygen extraction. Oxygen extraction (the
difference between arterial and mixed venous blood
oxygen saturations and expressed as percent) was
measured in 4 normal and 4 uremic sheep at dif-
ferent levels of hemoglobin (Fig. 10). There was a
similar signfficant linear increase in oxygen extrac-
tion as hemoglobin concentration decreased in both
the normal and uremic states.
(6) 2,3-DPG and P50. Five sheep had serial 2,3-
DPG determinations over a wide range in hemato-
crits (20 to 45%). Values for 2,3-DPG varied be-
tween 0.33 and 0.87 /LM of phosphate per milliliter
of packed red cells. Eight sheep had P50 determina-
tions made over a similar hematocrit range (13 to
1 500
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Fig. 7. Relationship of hemoglobin concentration to renal blood flow (left side) and when expressed as that fraction of the cardiac output
(CO) going to the kidney (right side).
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41%). The P50 values varied between 25.7 and 34.9
mm Hg. There were no correlations between either
2,3-DPG or P50 and hematocrit noted in the groups
as a whole. In addition, no cross-correlations be-
tween 2,3-DPG and P50 were noted.
Discussion
The kidney participates in erythropoiesis through
its regulation and production of the erythropoietic
stimulating hormone, erythropoietin [29]. The regu-
lation of erythropoietin production by the kidney is
the result of complex interactions related to oxygen
delivery [30-32]. Oxygen delivery to a given organ
is directly related to the level of hemoglobin (oxy-
gen carrying capacity) in the blood, to cardiac out-
E
0
put (CO), and, in many animals including man, to
factors that affect the loading and unloading of oxy-
gen from the hemoglobin molecule. Those factors of
primary importance in determining oxygen-hemo-
globin dissociation characteristics are intra-
erythrocytic and plasma pH, 2,3-DPG content of
red cells, and hemoglobin type. Many aspects of
these relationships have only recently been defined
[33—36].
With anemia, tissue oxygen delivery is impaired
primarily by the decreased oxygen content of the
blood. In many species, a number of compensatory
adjustments occur that improve tissue oxygenation.
Typical of these are the increases in CO and in red
cell levels of 2,3-DPG which reduce hemoglobin af-
finity for oxygen and thus promote oxygen unload-
ing at tissue sites. That these compensations are in-
complete is evident from the increased ESF and re-
ticulocyte production in the face of continued
anemia.
We have undertaken to study in greater detail the
interactions between the kidney/erythroid marrow
and oxygen delivery in both the normal state and in
the anemia of CRF. A large animal model, the
sheep, was used because it is difficult to investigate
these factors extensively in a serial fashion in hu-
man subjects, and other animal models are not ap-
propriate for large blood volume manipulations or
long-term dialysis [16].
Red cell production and oxygen delivery were
first defined for normal sheep in a basal state and
then under experimentally-induced changes in he-
moglobin concentration, that is, either via phle-
botomy-induced anemia or hypertransfusion. Other
sheep were subtotally nephrectomized and then
similar experimental manipulations were performed
in the uremic setting. Ideally, the sheep model al-
lows for each animal to serve as its own control pri-
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Fig. 8. Oxygen utilization related to hemoglobin levels in normal
and uremic states. The number of animals studied are shown in
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or to the creation of the uremic state. Because the
feasibility of the model was being established [15,
16], most uremic sheep in this study did not have
prior control studies. The large number of studies in
normal sheep, however, makes comparisons to the
results of studies in the uremic state meaningful.
The stimulus for erythropoiesis in normal sheep is
similar to that in man in that it is mediated by changes
in renal production of erythropoietin. With anemia,
erythropoietin became measurable in serum and in-
creased as anemia was accentuated by phlebotomy.
The presence of HbC in circulation provided anoth-
er indirect measure of erythropoietin stimulation.
Normal adult sheep have three hemoglobin pheno-
types: HbAA (a2/32') HbBB (iazf32B), and HbAB
(at/3Af3B), the heterozygous state. Sheep of HbAA
or HbAB phenotype are able to "switch" on the
production of a new beta chain, f3, in response to
hypoxia or anemia [37]. This results in the produc-
tion of a new hemoglobin HbC, either as the homo-
zygous form, a2f32C, or as the heterozygous form
a2f3f3. Both in vivo and in vitro studies have con-
clusively demonstrated that erythropoietin acti-
vates HbC synthesis [17, 38].
The response of sheep to phlebotomy-induced
anemia and transfusion was also reflected appropri-
ately by quantitative ferrokinetic studies. For in-
stance, erythropoiesis, as measured by the plasma
iron turnover, doubled with a 35% decrease in hem-
atocrit and was reduced by hypertransfusion, con-
firming the feedback mechanism between tissue ox-
ygen supply and erythroid marrow response. The
increase in the plasma iron turnover was accom-
panied by an increase in serum erythropoietin, in-
creased HbC synthesis, and a decrease in marrow
transit time.
Despite the anemia induced in the normal sheep
by phlebotomy, tissue oxygen utilization in the rest-
ing animal remained relatively unchanged, although
there were changes in the distribution of blood flow.
While CO increased, the fraction going to the kid-
ney decreased, reflecting a shunting of blood to
more essential organs. Such redistribution of flow
away from the kidney would result in a greater stim-
ulus for erythropoietin production proportional to
the degree of anemia.
Values for 2,3-DPG and P50 were unaltered in
anemic sheep, as has been reported by others [39],
and, therefore, play little or no role in the sheep's
compensation to hypoxia. The configuration of
sheep hemoglobin is such that 2,3-DPG is unable to
form a link between the two beta globin chains, sta-
bilizing them in the deoxygenated form [40] and,
therefore, does not influence heme-heme inter-
action as it does in human hemoglobin. In sheep,
oxygen extraction from blood, as reflected by the
Po2 and arterial-venous oxygen saturation dif-
ference, increased linearly with increasing anemia.
This is different than the response in humans [28],
where increases in intraerythrocytic 2,3-DPG and
the rightward shift of the 0-hemoglobin dissociation
curve enhance tissue oxygen delivery [23].
Significantly, erythropoiesis in the uremic sheep
is similar to that in the human with CRF in that the
anemia is hypoproliferative as quantitated by fer-
rokinetic studies, and red cell survival is essentially
normal [41-43]. With increasing uremia, the plasma
iron turnover and erythroid iron turnover decrease
014
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Fig. 10. Oxygen extraction at different levels of hemoglobin concentration in 4 normal and 4 uremic sheep. Note the linearity of the
slopes. Individual slopes were similar to that of the group.
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and the marrow transit time lengthens in com-
parison with that of the normal, phiebotomized
state. Despite this hypoproliferative condition,
however, erythropoiesis appears to be under the
same regulatory feedback mechanism in both the
normal and uremic state—that is, as blood oxygen
carrying capacity changes, there is an inverse effect
on red cell production. Thus, erythropoiesis, as
measured by the plasma iron turnover, increased
one and one-half times in uremic, anemic animals
that had been further stressed by phlebotomy. The
marrow transit time, a reflection of erythropoietic
stimulus, shortened by 43% in the normal sheep
stimulated by anemia, whereas in uremic sheep it
shortened by 30% when phlebotomy induced a
comparable reduction in blood oxygen carrying ca-
pacity. Although fewer studies in the hyper-
transfused state were performed, erythropoiesis
was suppressed in both normal and uremic animals.
These studies demonstrate the ability of the
erythron to respond appropriately to further tissue
hypoxia or hyperoxia, and imply that a normal feed-
back mechanism also exists in renal failure, al-
though the magnitude of the response may be less in
the uremic state.
Tissue oxygen utilization in anemic, uremic
sheep was maintained similar to that in phleboto-
mized normal sheep. This compensation was due to
an increase in cardiac output, shunting of blood
away from the kidneys, and a linear increase in oxy-
gen extraction from venous blood. Renal disease re-
sults in an absolute reduction in RBF, providing an
even greater shunting of CO to other organs, hence
maintaining oxygen availability to tissue.
The mechanism underlying the changes in
erythropoiesis in uremic sheep, when stimulated
with phlebotomy or suppressed with transfusion,
probably is the same as it is in normal sheep, but the
data are more difficult to interpret. The failure of
erythropoietin to increase to detectable levels in all
the very anemic, uremic sheep may be because of
the known insensitivity of the assay for erythro-
poietin, particularly to monitor small changes. It is
of interest, however, that 2 dialyzed sheep had evi-
dence of erythropoietin stimulation when their hem-
atocrits were reduced below 18% by phlebotomy.
Unfortunately, we do not have data to clarify
whether the increased production is from renal or
nonrenal sources, to the removal by dialysis of tox-
ins, or both. Dialysis has improved erythropoiesis
in humans [44].
These studies in normal and uremic sheep of the
response to changes in oxygen-carrying capacity
demonstrate the similarity of the uremic sheep mod-
el to its human counterpart. Red cell production ap-
pears to remain under the control of erythropoietin
and to respond appropriately to deliberate altera-
tions in tissue oxygen availability. There is little di-
rect evidence suggesting that uremic toxins play an
important pathophysiologic role in this setting.
Further studies with this model should provide
additional information about the mechanisms of the
anemia associated with CRF. In contrast to patients
with renal failure, the sheep can be extensively ma-
nipulated for experimental purposes, and selected
animals have an additional monitor of erythro-
poietin effectiveness, the switch from HbA to HbC
synthesis. In view of these results and the ability to
create a uremic animal that can be maintained with
dialysis, further studies, such as the response to ex-
ogenous erythropoietin administration in the nor-
mal and uremic state and the influence of altered
dialysis techniques on marrow function, become
feasible.
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